Feature

Skin cancer procedures up by 35% since 2012


 

The number of skin cancer procedures in 2016 was up by 10.5% since 2015 and by 35% since 2012, according to the American Society for Dermatologic Surgery.

Of the estimated 3.5 million skin cancer treatments provided by dermatologic surgeons in 2016, just over 227,000, or 6.5%, were for melanoma – a 4% increase over those diagnosed in 2015. Since 2012, the annual number of melanoma procedures has risen by 55%. The 3.29 million nonmelanoma procedures performed in 2016 represent a 10% increase over 2015, the ASDS said in a report on its 2016 Survey on Dermatologic Procedures.

“The public is increasingly aware of the need to have any new or suspicious lesions checked,” ASDS President Thomas Rohrer, MD, said in a written statement.

In addition to the skin cancer treatments, ASDS members also performed over 7 million cosmetic procedures in 2016, including 2.8 million involving laser, light, and energy-based devices. Additionally, 1.7 million involving neuromodulators, and 1.35 million involved soft-tissue fillers, the ASDS said.

The procedures survey was conducted Jan. 4 to Feb. 8, 2017, and included 627 physicians’ responses, which were then generalized to represent all of the almost 6,100 ASDS members.

Over 3.5 million skin cancer treatments performed in 2016
rfranki@frontlinemedcom.com

Recommended Reading

Racial differences in skin cancer risk after organ transplantation
MDedge Hematology and Oncology
FDA approves first treatment for metastatic Merkel cell carcinoma
MDedge Hematology and Oncology
Avelumab produces durable responses in Merkel cell carcinoma
MDedge Hematology and Oncology
Reflectance confocal microscopy offers one-stop solution for BCC
MDedge Hematology and Oncology
Merkel cell carcinoma most likely to recur within 2 years of diagnosis
MDedge Hematology and Oncology
Tattoo artist survey finds almost half agree to tattoo skin with lesions
MDedge Hematology and Oncology
Chronic GVHD linked to fivefold increase in squamous cell skin carcinomas
MDedge Hematology and Oncology
Study links photosensitizing antihypertensives to SCC
MDedge Hematology and Oncology
Skin cancer risk similar for liver and kidney transplant recipients
MDedge Hematology and Oncology
Mupirocin plus chlorhexidine halved Mohs surgical-site infections
MDedge Hematology and Oncology